Pulse Biosciences CFO Sandra Gardiner resigns; search for successor underway

PULSE BIOSCIENCES, INC.

Sandra Gardiner, CFO of Pulse Biosciences, resigned on November 30, 2022.
Resignation not due to any disagreement with the company on operations or accounting.
Company expects to promptly begin a search for Ms. Gardiner’s successor.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sandra Gardiner

Chief Financial Officer

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2022-11-30
Filed: December 6, 2022, 6:59 PM ET

On November 30, 2022, Sandra Gardiner, the Chief Financial Officer of Pulse Biosciences, Inc. (the “Company”) gave notice that she was resigning from the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Sandra Gardiner resigned as Chief Financial Officer at PULSE BIOSCIENCES, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On November 30, 2022, Sandra Gardiner, the Chief Financial Officer of Pulse Biosciences, Inc. (the “Company”) gave notice that she was resigning from the Company.

View on SEC.gov

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001625101-22-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.